Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Foreman

Showing results (261-270 of 326) with videos related to

Pageof 33
Sort By:
Cell Reports|April 9, 2020
Super Elongation Complex as a Targetable Dependency in Diffuse Midline GliomaNathan A Dahl, Etienne Danis, Ilango Balakrishnan, et al.
Acta Neuropathologica|November 19, 2013
Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymomaLindsey M Hoffman, Andrew M Donson, Ichiro Nakachi, et al.
Journal for Immunotherapy of Cancer|January 20, 2015
CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapyChristopher L Moertel, Junzhe Xia, Rebecca LaRue, et al.
JAMA Otolaryngology-- Head & Neck Surgery|March 28, 2024
Neoadjuvant-Intent Immunotherapy in Advanced, Resectable Cutaneous Squamous Cell CarcinomaEmily Y Kim, Emily S Ruiz, Mia S DeSimone, et al.
Research Square|August 23, 2023
Genetic Predictors of Neurocognitive Outcomes in Survivors of Pediatric Brain TumorsSydney T Grob, Kristen R Miller, Bridget Sanford, et al.
Journal of Neuro-Oncology|October 25, 2023
Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumorsSydney T Grob, Kristen R Miller, Bridget Sanford, et al.
Molecular Cancer Therapeutics|June 22, 2018
Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood EpendymomaAndrew M Donson, Vladimir Amani, Elliot A Warner, et al.
Pediatric Blood & Cancer|January 20, 2018
Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapyDavis A Witt, Andrew M Donson, Vladimir Amani, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Rapid PTEFb-dependent transcriptional reorganization underpins the glioma adaptive response to radiotherapyFaye M Walker, Lays Martin Sobral, Etienne Danis, et al.
Cancer Immunology Research|May 14, 2015
Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A EpendymomaAndrea M Griesinger, Rebecca J Josephson, Andrew M Donson, et al.
Pageof 33

Showing results (261-270 of 326) with videos related to

Sort By:
Pageof 33
Cell Reports|April 9, 2020
Super Elongation Complex as a Targetable Dependency in Diffuse Midline GliomaNathan A Dahl, Etienne Danis, Ilango Balakrishnan, et al.
Acta Neuropathologica|November 19, 2013
Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymomaLindsey M Hoffman, Andrew M Donson, Ichiro Nakachi, et al.
Journal for Immunotherapy of Cancer|January 20, 2015
CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapyChristopher L Moertel, Junzhe Xia, Rebecca LaRue, et al.
JAMA Otolaryngology-- Head & Neck Surgery|March 28, 2024
Neoadjuvant-Intent Immunotherapy in Advanced, Resectable Cutaneous Squamous Cell CarcinomaEmily Y Kim, Emily S Ruiz, Mia S DeSimone, et al.
Research Square|August 23, 2023
Genetic Predictors of Neurocognitive Outcomes in Survivors of Pediatric Brain TumorsSydney T Grob, Kristen R Miller, Bridget Sanford, et al.
Journal of Neuro-Oncology|October 25, 2023
Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumorsSydney T Grob, Kristen R Miller, Bridget Sanford, et al.
Molecular Cancer Therapeutics|June 22, 2018
Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood EpendymomaAndrew M Donson, Vladimir Amani, Elliot A Warner, et al.
Pediatric Blood & Cancer|January 20, 2018
Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapyDavis A Witt, Andrew M Donson, Vladimir Amani, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Rapid PTEFb-dependent transcriptional reorganization underpins the glioma adaptive response to radiotherapyFaye M Walker, Lays Martin Sobral, Etienne Danis, et al.
Cancer Immunology Research|May 14, 2015
Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A EpendymomaAndrea M Griesinger, Rebecca J Josephson, Andrew M Donson, et al.
Pageof 33